Breast Cancer, Aiom: "Patients Still Little Informed About Oncology Accuracy"
This story is only covered by news sources that have yet to be evaluated by the independent media monitoring agencies we use to assess the quality and reliability of news outlets on our platform. Learn more here.7 Articles
7 Articles
The women with breast cancer and their caregivers still know little about precision oncology, an approach that allows to identify the molecular characteristics of the tumor and choose more targeted treatments. Only 32% of the respondents know that the liquid biopsy is a blood test that allows to identify the presence of [...]
canaledieci.it
The women with breast cancer and their caregivers still know little about precision oncology, an approach that allows to identify the molecular characteristics of the tumor and choose more targeted treatments. Only 32% of the respondents know that the liquid biopsy is a blood test that allows to identify the presence of [...]
notizie.it
Rec News | Lontani dal mainstream(Adnkronos) - Women with breast cancer and their caregivers still know little about precision oncology, an approach that allows to identify
Coverage Details
Bias Distribution
- There is no tracked Bias information for the sources covering this story.
Factuality
To view factuality data please Upgrade to Premium
